These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10523007)
1. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. Bonnema SJ; Bertelsen H; Mortensen J; Andersen PB; Knudsen DU; Bastholt L; Hegedüs L J Clin Endocrinol Metab; 1999 Oct; 84(10):3636-41. PubMed ID: 10523007 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration. Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L J Clin Endocrinol Metab; 2008 Oct; 93(10):3981-4. PubMed ID: 18664541 [TBL] [Abstract][Full Text] [Related]
3. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L J Clin Endocrinol Metab; 2007 Sep; 92(9):3424-8. PubMed ID: 17566091 [TBL] [Abstract][Full Text] [Related]
4. Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging. Bonnema SJ; Knudsen DU; Bertelsen H; Mortensen J; Andersen PB; Bastholt L; Hegedüs L Thyroid; 2002 Apr; 12(4):313-7. PubMed ID: 12034056 [TBL] [Abstract][Full Text] [Related]
5. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951 [TBL] [Abstract][Full Text] [Related]
6. Large, compressive goiters treated with radioiodine. Huysmans DA; Hermus AR; Corstens FH; Barentsz JO; Kloppenborg PW Ann Intern Med; 1994 Nov; 121(10):757-62. PubMed ID: 7944053 [TBL] [Abstract][Full Text] [Related]
7. Improvement of upper airway obstruction after 131I-treatment of multinodular nontoxic goiter evaluated by flow volume loop curves. Nygaard B; Søes-Petersen U; Høilund-Carlsen PF; Veje A; Holst PE; Vestergaard A; Sølling K J Endocrinol Invest; 1996 Feb; 19(2):71-5. PubMed ID: 8778168 [TBL] [Abstract][Full Text] [Related]
8. Iodine-131 therapy in sporadic nontoxic goiter. de Klerk JM; van Isselt JW; van Dijk A; Hakman ME; Pameijer FA; Koppeschaar HP; Zelissen PM; van Schaik JP; van Rijk PP J Nucl Med; 1997 Mar; 38(3):372-6. PubMed ID: 9074521 [TBL] [Abstract][Full Text] [Related]
14. MR imaging of large multinodular goiters: observer agreement on volume versus observer disagreement on dimensions of the involved trachea. Bonnema SJ; Andersen PB; Knudsen DU; Hegedüs L AJR Am J Roentgenol; 2002 Jul; 179(1):259-66. PubMed ID: 12076947 [TBL] [Abstract][Full Text] [Related]
15. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656 [TBL] [Abstract][Full Text] [Related]
16. Standard dose 131I therapy for toxic multinodular goiter in an endemic goiter region. Gonçalves E; Castro JA; Gross JL Braz J Med Biol Res; 1986; 19(6):723-9. PubMed ID: 3651625 [TBL] [Abstract][Full Text] [Related]
17. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
18. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. Graf H; Fast S; Pacini F; Pinchera A; Leung A; Vaisman M; Reiners C; Wemeau JL; Huysmans D; Harper W; Driedger A; de Souza HN; Castagna MG; Antonangeli L; Braverman L; Corbo R; Düren C; Proust-Lemoine E; Edelbroek MA; Marriott C; Rachinsky I; Grupe P; Watt T; Magner J; Hegedus L J Clin Endocrinol Metab; 2011 May; 96(5):1368-76. PubMed ID: 21346067 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346 [TBL] [Abstract][Full Text] [Related]
20. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study. Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]